TEAR
$0.09
Tearlab
TEAR
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Thursday
Jun 20
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when TEAR reports earnings?
Beat
Meet
Miss

Where is TEAR's stock price going from here?
Up
Flat
Down
Stock chart of TEAR
Analysts
Summary of analysts' recommendations for TEAR
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
TearLab Corporation is an ophthalmic device company developing and commercializing novel, lab-on-a-chip technologies that enable eye care practitioners to test for highly sensitive and specific biomarkers in tears at the point-of-care. The Company is commercializing a proprietary in vitro diagnostic tear testing platform, the TearLabTM Osmolarity System, which is capable of accurately and rapidly measuring biomarkers in tears at the point-of-care. The TearLabTM System requires nanoliters of tears for testing, potentially reducing collection time and simplifying the tear collection process. TearLab Corporation, formerly known as OccuLogix Inc., is headquartered in San Diego, California.
Peers
Myriad GeneticsImmunomedicsQuidelCareDxMeridian BioscienceSurModics